Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 26, 2026
TickeronGET DAILY SIGNALS
Brown & Brown (BRO) Posts 7.4% Revenue Rise in Q3 With Organic Growth at 1.2%

Brown & Brown (BRO) Posts 7.4% Revenue Rise in Q3 With Organic Growth at 1.2%

Key Takeaways

  • Total revenues rose 7.4% year over year to $1.725 billion, driven primarily by acquisitions rather than underlying expansion.
  • Organic revenue growth slowed to just 1.2% in the quarter, or 1.5% when including contingent commissions.
  • Diluted net income per share (EPS) declined 1.5% to $0.67, while adjusted diluted EPS increased 1.9% to $1.07.
  • Reported results came in below analyst expectations for both revenue and adjusted earnings per share.
  • Net income attributable to the company rose 5.7% to $240 million, and income before income taxes increased 2.9% to $320 million.

Putting the Earnings in Context

Brown & Brown, Inc. (BRO) ranks among the largest U.S. insurance brokerages, earning revenue mainly through commissions and fees in its Retail and Programs segments. The company has expanded heavily via acquisitions, so investors focus closely on organic revenue growth to gauge how the core business is performing without the boost from new additions. The third quarter of 2026 matters because it shows whether Brown & Brown can maintain momentum after the large Accession deal while navigating softer property and casualty insurance conditions. Slower organic growth and a slight earnings miss may shape how the stock is valued into year-end.

The Quarter’s Reported Numbers

For the third quarter ended September 30, 2026, Brown & Brown reported total revenues of $1.725 billion, up $119 million or 7.4% from $1.606 billion a year earlier. Organic revenue advanced 1.2%, and organic revenue including contingents rose 1.5%. Diluted net income per share came in at $0.67, down 1.5% from $0.68 in the prior-year period. Adjusted diluted net income per share climbed 1.9% to $1.07 from $1.05. Net income attributable to the company increased 5.7% to $240 million.

Results fell short of consensus estimates. Analysts polled by Investing.com had expected revenue near $1.76 billion and adjusted EPS around $1.09, so both the top line and adjusted earnings missed forecasts. The modest organic growth, separate from acquisition effects, remained the main focus for investors.

I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Market Reaction and Investor Sentiment

Heading into the report, sentiment was already measured, with Brown & Brown shares down roughly 10% year to date as of late October 2026 and trailing the broader S&P 500. After the release, early after-hours trading showed a muted, modestly positive move as the market balanced softer organic growth against resilient adjusted profits. The earnings miss on revenue and adjusted EPS appeared to limit immediate enthusiasm, while continued acquisition-driven revenue growth and stable profitability provided some offset. Investors are watching to see if organic momentum can pick up in coming quarters.

Forward Outlook and Factors to Monitor

The key signal for investors will be the path of organic revenue growth. The 1.2% figure in the third quarter points to modest underlying demand, and management has noted that fourth-quarter organic growth could resemble the third quarter. Acquisitions, including the Accession transaction, continue to support headline revenue, but the market will increasingly look for self-generated expansion.

Profitability trends also deserve attention. Brown & Brown reports a non-GAAP measure called EBITDAC—earnings before interest, taxes, depreciation, amortization, and changes in estimated acquisition earn-out payables. Margin movements here help gauge how efficiently acquired businesses are integrated and expenses are controlled.

Capital allocation remains another important theme. Brown & Brown has a solid history of dividend increases and share repurchases that provide support for the stock. Investors will track guidance updates, contingent commission trends, and any additional merger and acquisition activity as the company balances acquisition-driven growth with better organic performance.

Refining My Analysis With Tickeron’s AI Screener

In my own review of insurance brokerage names, I often turn to Tickeron’s AI Screener to quickly filter peers by fundamentals, technical patterns, and performance metrics. It helps surface comparable ideas and track sector momentum without manual effort, which proved useful when examining Brown & Brown’s results alongside industry trends.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BRO

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


BRO in upward trend: price rose above 50-day moving average on October 29, 2026

BRO moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend. In 25 of 31 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 20, 2026. You may want to consider a long position or call options on BRO as a result. In 43 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 54%.

The 10-day moving average for BRO crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.

Following a +4.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where BRO advanced for three days, in 175 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.

The Aroon Indicator entered an Uptrend today. In 175 of 295 cases where BRO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.

Bearish Trend Analysis

The 10-day RSI Indicator for BRO moved out of overbought territory on October 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 19 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 43%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 33 of 59 cases where BRO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 56%.

The Moving Average Convergence Divergence Histogram (MACD) for BRO turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 26 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.

BRO broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. BRO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 68 (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 71 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.918) is normal, around the industry mean (2.794). P/E Ratio (20.202) is within average values for comparable stocks, (19.877). Projected Growth (PEG Ratio) (0.910) is also within normal values, averaging (8.322). Dividend Yield (0.010) settles around the average of (0.042) among similar stocks. P/S Ratio (3.322) is also within normal values, averaging (3.106).

The Tickeron Profit vs. Risk Rating rating for this company is 88 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

Notable companies

The most notable companies in this group are eHealth (NASDAQ:EHTH).

Industry description

Insurance brokers sell, solicit, or negotiate insurance for compensation. General insurance brokers mostly cater to insurances on car, house etc. (versus life). Brokers are also often instrumental in helping small employers find health insurance, particularly in more competitive markets. Additionally, brokers may also provide risk assessments, insurance consulting services, insurance-related regulatory and legislative update services. Some of the major names in this industry include Marsh & McLennan Companies, Inc., Aon plc and Verisk Analytics Inc.

Market Cap

The average market capitalization across the Insurance Brokers/Services Industry is 16B. The market cap for tickers in the group ranges from 3.03K to 97.74B. MRSH holds the highest valuation in this group at 97.74B. The lowest valued company is CUII at 3.03K.

High and low price notable news

The average weekly price growth across all stocks in the Insurance Brokers/Services Industry was -9%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 17%. CRVL experienced the highest price growth at 3%, while ZBAO experienced the biggest fall at -66%.

Volume

The average weekly volume growth across all stocks in the Insurance Brokers/Services Industry was -73%. For the same stocks of the Industry, the average monthly volume growth was 7% and the average quarterly volume growth was -5%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 74
Price Growth Rating: 51
SMR Rating: 70
Profit Risk Rating: 84
Seasonality Score: 8 (-100 ... +100)
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of insurance brokerage services and casualty insurance underwriting services

Industry InsuranceBrokersServices

Industry
Insurance Brokers Or Services
Address
300 North Beach Stree
Phone
+1 386 252-9601
Employees
14531
Web
https://www.bbinsurance.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.